21 research outputs found
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
In a randomized, double-blind, Phase III study, we compared pasireotide long-acting
release (pasireotide LAR) with octreotide long-acting repeatable (octreotide LAR) in managing
carcinoid symptoms refractory to first-generation somatostatin analogues. Adults with carcinoid
tumors of the digestive tract were randomly assigned (1:1) to receive pasireotide LAR (60 mg)
or octreotide LAR (40 mg) every 28 days. Primary outcome was symptom control based on
frequency of bowel movements and flushing episodes. Objective tumor response was a secondary
outcome. Progression-free survival (PFS) was calculated in a post hoc analysis. Adverse
events were recorded. At the time of a planned interim analysis, the data monitoring committee
recommended halting the study because of a low predictive probability of showing superiority
of pasireotide over octreotide for symptom control (n=43 pasireotide LAR, 20.9%; n=45
octreotide LAR, 26.7%; odds ratio, 0.73; 95% confidence interval [CI], 0.27–1.97; P=0.53).
Tumor control rate at month 6 was 62.7% with pasireotide and 46.2% with octreotide (odds
ratio, 1.96; 95% CI, 0.89–4.32; P=0.09). Median (95% CI) PFS was 11.8 months (11.0 – not
reached) with pasireotide versus 6.8 months (5.6 – not reached) with octreotide (hazard ratio,
0.46; 95% CI, 0.20–0.98; P=0.045). The most frequent drug-related adverse events (pasireotide
vs octreotide) included hyperglycemia (28.3% vs 5.3%), fatigue (11.3% vs 3.5%), and nausea
(9.4% vs 0%). We conclude that, among patients with carcinoid symptoms refractory to available
somatostatin analogues, similar proportions of patients receiving pasireotide LAR or octreotide
LAR achieved symptom control at month 6. Pasireotide LAR showed a trend toward higher
tumor control rate at month 6, although it was statistically not significant, and was associated
with a longer PFS than octreotide LAR
Efeitos tardios dos praguicidas organoclorados no homem Delayed effects of organochlorine pesticides in man
Procurou-se relacionar as informações disponíveis sobre os organoclorados e os efeitos crônicos provocados pela exposição. Os compostos organoclorados são os praguicidas mais persistentes já fabricados. Embora sejam geralmente eficientes no controle das pragas, são importantes poluentes ambientais e potenciais causas de problemas de saúde para o homem, tendo sido proibidos ou controlados na maioria dos países. Com poucas exceções, os efeitos tardios desses compostos sobre a saúde humana são difíceis de detectar, em função de dificuldades metodológicas e da extrapolação dos resultados. A genotoxicidade está entre os mais sérios dos possíveis danos causados por esses compostos e merece atenção especial, devido à natureza irreversível do processo. Outro ponto a ser considerado é o aumento na incidência de alterações no desenvolvimento do trato reprodutivo e na fertilidade masculina observada nas últimas décadas provavelmente decorrente do aumento da exposição intra-uterina a compostos estrogênicos e anti-androgênicos, como os organoclorados.<br>Available information on organochlorines and the chronic effects of exposure to them are set out. Organochlorinated compounds are the most persistent pesticides and can be found in all ecosystems. Although they are generally efficient in pest control, they are also a potent environment pollutant and can provoke health problems in man. The evidences of the carcinogenic potential of organochlorines are controversial and insufficient, but they have been related to an increase in the incidence of some kinds of tumors, such as leukemia and solid tumors. Reproductive effects, due to anti-androgenic and estrogenic action, on embryonic virilization, the incidence of abortion and the frequency of prematurity, have also been observed. The accumulation of the organochlorines in the adipous tissue is positively correlated to the increase in aging and could be implicated in the development of aging diseases, such as Parkinson's disease. The effects of pesticides on human health have not yet been completely elucidated. Genotoxicity is one of the most serious of the possible harmful effects caused by these compounds and calls for special attention in view of the irreversible nature of the process and to the long latency associated with its manifestation
DATICS-2010: Welcome message from workshop organizers: FutureTech 2010
10.1109/FUTURETECH.2010.54826432010 5th International Conference on Future Information Technology, FutureTech 2010 - Proceedings
Preface of the 2010 IAENG International Conference on Electrical Engineering special session: Design, analysis and tools for integrated circuits and systems
Proceedings of the International MultiConference of Engineers and Computer Scientists 2010, IMECS 20101333-133